EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, STOK: Stoke Therapeutics Inc

07 Oct 26 15:59
LAST:

24.30

CHANGE:
 0.08		OPEN:
24.45		HIGH:
24.70		ASK:
0.00		VOLUME:
198.7K
CHG(%):
0.33		PREV:
24.37		LOW:
23.95		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Oct 2624.1324.7023.9524.29637.0K
06 Oct 2625.5825.7323.0024.371.17M
05 Oct 2625.8226.3124.8425.32928.3K
02 Oct 2626.4526.4625.4525.62848.6K
01 Oct 2626.0626.5125.9126.011.16M
30 Sep 2626.1226.6925.8826.001.87M
29 Sep 2625.3125.9925.1225.881.08M
28 Sep 2624.5125.7124.2125.501.66M
25 Sep 2625.4725.5224.8024.801.22M
24 Sep 2626.0926.3025.0025.291.22M

PROFILE

Name:Stoke Therapeutics Inc
About:Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase I/II clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:45 Wiggins Avenue, Bedford, MA, United States, 01730
Website:https://www.stoketherapeutics.com
CUSIP:86150R107
CIK:0001623526
ISIN:US86150R1077
FIGI:BBG00JPCBPG9
LEI:549300RD25SS2DIJHJ67

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:51.72 
Forward P/E:-7.29 
PEG Ratio:-2.65 
Price to Sales:8.24 
Price to Book:4.63 
Profit Margin:0.26 
Operating Margin:-1.98 
Return on Assets:0.07 
Return on Equity:0.18 
EPS Ratio:-3.38 
Revenue:199.89M 
EBITDA:42.27M 
Shares:64.53M 
Market Cap:1.568B 

TECHNICAL INDICATORS

MA5:25.123.4%
MA10:25.314.1%
MA20:26.8910.7%
MA50:29.6221.9%
MA100:29.9723.3%
MA200:31.5329.8%
RSI14:25.21 
WPR14:-100.00 
MTM14:-4.14
ROC14:-0.15 
ATR:1.31 
Week High:26.699.8%
Week Low:23.005.7%
Month High:30.6826.3%
Month Low:23.0029.8%
Year High:40.2265.5%
Year Low:20.3219.6%
Volatility:9.52